Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists.

Bioorg Med Chem Lett

Department of Discovery Chemistry, Bristol-Myers Squibb, Research and Development, PO Box 5400, Princeton, NJ 08543-5400, United States.

Published: March 2013

Previously disclosed C6 amido and benzimidazole dihydropyrazolopyrimidines were potent and selective blockers of IKur current. Syntheses and SAR for C6 triazolo and imidazo dihydropyrazolopyrimidines series are described. Trifluoromethylcyclohexyl N(1) triazole, compound 51, was identified as a potent and selective Kv1.5 inhibitor with an acceptable PK and liability profile.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2013.01.064DOI Listing

Publication Analysis

Top Keywords

triazolo imidazo
8
potent selective
8
imidazo dihydropyrazolopyrimidine
4
dihydropyrazolopyrimidine potassium
4
potassium channel
4
channel antagonists
4
antagonists disclosed
4
disclosed amido
4
amido benzimidazole
4
benzimidazole dihydropyrazolopyrimidines
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!